• FDA Outlines Upcoming Regulatory Changes And Urges Industry To Be Proactive And Transparent
    FDA Outlines Upcoming Regulatory Changes And Urges Industry To Be Proactive And Transparent

    While reviewing upcoming changes heading industry’s way through regulatory legislations, such as the Food and Drug Administration Safety and Innovation Act (FDASIA) and the Drug Supply Chain Security Act (DSCSA), during her keynote session at Pack Expo 2014, Ricki Chase, director of investigations for the FDA’s Chicago office, urged the audience to not just focus on product integrity, but also personal and corporate integrity.

More From The Editor


  • Enhancing Isolator H2O2 Decontamination Processes
    Enhancing Isolator H2O2 Decontamination Processes

    Hydrogen Peroxide (H2O2) decontamination is the most widely used and accepted form of decontamination in isolators.

  • Overcoming Challenges In Virus Removal
    Overcoming Challenges In Virus Removal

    Biotechnological and biological therapeutic products are often manufactured using materials of animal or human origin, which carry a risk of being contaminated with either known or unknown viruses.

  • The Renaissance Of Sprinkle Formulations
    The Renaissance Of Sprinkle Formulations

    By Sven Stegemann, PhD, Capsugel

    About 25 years ago, multi-particulates were applied in pharmaceutical product development as so-called sprinkle formulations to overcome swallowing issues with larger oral dosage forms. After a growth in popularity in the 1990s, use of sprinkle formulations declined because of concerns about delivery and efficacy. These issues, which can easily be overcome, are addressed in this article.

  • Private Branding: How On-Demand Color Labeling Can Add Value To The Growing Generics Market

    The generics market has taken off in recent years due to numerous patent expirations for brand-name companies. In light of this, pharmaceutical manufacturers, insurance companies and consumers, in search of significant cost savings, have turned towards the generics industry.

  • Single-Use Technology: The Trust Factor
    Single-Use Technology: The Trust Factor

    What is missing today is trust. The axiom “trust but verify” is truer with single-use systems than in the past. The customer/supplier relationship required with single-use systems cannot be transactional, but must be a long term partnership for mutual success. This has to be built on a foundation of trust, and that is lacking today. For the end users, the implementation of single-use systems represents an outsourcing of critical operations, previously performed and controlled by their own people and quality management system.

More Pharma Mfg Insights


  • The Challenge Of Managing Regulatory Submissions & Correspondence

    Life science organizations produce large volumes of documents necessary for submitting applications to regulatory agencies. They need to have records of those documents as well as all related communications from sites around the world. This creates a situation that can be rather daunting.

    Sponsors must first make sure all documents are going through the proper review and approval cycle and that controls are in place to meet regulatory requirements such as 21 CFR part 11. Once the documents are published and ready for submission to the regulatory agency, they are typically stored on a file share. Although that file share has access controls in place, it will not have granular-level access controls.

  • ISPE Releases Drug Shortages Prevention Plan At Annual Meeting

    ISPE has released its Drug Shortages Prevention Plan at a media conference held during its annual meeting at Caesars Palace in Las Vegas. Present at the conference were new president and CEO John Bournas, strategic advisor John Berridge, and Drug Shortage Prevention Plan leaders Joe Famulare, Paul D'Eramo, Donna Gulbinski, and Sam Venugopal.

  • ISPE Set To Address Drug Shortages At Annual Meeting

    Drug shortages continue to plague the pharmaceutical industry. According to a GAO report on shortages, dated February 2014, the number of shortages continues to increase in the U.S., as well as around the world. In 2007 there were 154 shortages, 114 new shortages and 40 ongoing from a prior year. In 2012, there were 456 shortages, 195 news ones and 261 ongoing. As of June 30, 2013, there were already 73 new shortages and 288 ongoing.

    The public health importance of these shortages cannot be overemphasized. Shortage situations have included zinc for parenteral nutrition in neonates and premature infants, doxorubicin for ovarian and other cancers, and Propofol for anesthesia.

    Clearly something needs to be done. “ISPE believes efforts to address this complex and multi-faceted problem of drug shortages requires close collaboration and clear communication between the pharma industry and global health authorities,” says Francois Sallans, VP and chief quality officer for Johnson & Johnson, and presenter at the 2014 ISPE-FDA CGMP Conference. “We believe The Drug Shortages Prevention Plan being assembled by ISPE will provide guidance to pharma and global health authorities to manage drug shortages more effectively. But more importantly we are looking into ways for the two groups to manage these shortages more proactively as well. That is an important component that we need to have in place in order to make these shortages rare, but short-lived.”

  • What Can You Learn From The Educational Planning Process Of BIO?

    In my role as the 2015 co-chair of the BIO International’s educational planning committee, I am privy to what goes into creating one of our industry’s largest annual events. As many of you are involved in organizing your own customer educational programs (e.g., The Emerson Exchange) or have been asked to serve on an event planning committee, I thought a behind the scenes look into how BIO goes about the process would be helpful to your efforts. Here are some of the best business practices I have witnessed thus far.

  • Innovation In Clinical Trials: Is It Time To Change The Paradigm?

    “People hate change. This is true in the life sciences industry and everywhere in the world. I think it’s a major, major problem.”

    That statement, by Glen de Vries, president of Medidata, seems to sum up the challenge many have with trying to bring down the cost of clinical trials. To bring down costs we need to implement new, efficient, and available technologies. Unfortunately implementing new technologies involves change, which many people in this industry do not seem to want to embrace.

    Hopefully, that attitude may soon be changing. One of the trends de Vries has seen in the past year is a focus on innovation originating at the executive level. More managers, especially those in the C-suite, are saying we need to figure out how to do things differently.

More From Pharma Contributing Editors


  • It Might Look Like Just A Box - But It's A Lot More Than That
    It Might Look Like Just A Box - But It's A Lot More Than That

    Envirotainer R&D continuously strives to improve reliability – it is core of all our operations. As a market leader, Envirotainer also takes on the role of driving innovation of existing products and solutions for the future.

  • Cold Chain Open House 2014 Webinar
    Cold Chain Open House 2014 Webinar

    Camille Madelon, Strategy and Business Development Director, states, “The industry needs innovation to stay competitive and relevant in the future – to meet new demands, for example due to changing regulations, emerging markets and new drug segments such as personalized medicine.”

  • Global Study Reveals The future Of Temperature Control Packaging
    Global Study Reveals The future Of Temperature Control Packaging

    Sonoco ThermoSafe, a leading global provider of temperature assurance packaging, has revealed the results of its survey entitled “Assessing the Future of the Cold Chain Industry.” The survey highlights forward-looking trends in areas that significantly impact the cold chain industry – including environmental, trends, logistics and products and services. The survey’s 165 respondents spanned more than 20 countries and five continents.

  • Introduction to Multivariate Data Analysis
    Introduction to Multivariate Data Analysis

    Brad Swarbrick, Vice President of Business Development at CAMO Software, gives a short introduction to multivariate data analysis, discusses some of its applications and how these powerful analytical tools are being used to improve products and manufacturing processes in a wide range of industries.

  • Introduction to Pharmaceutical Bag Filling and Sealing Equipment
    Introduction to Pharmaceutical Bag Filling and Sealing Equipment

    Umbra bag filling and sealing machinery for all sorts of dry products in the food, pharmaceutical, chemical, and agricultural industries. A single Umbra packaging machine can fill bags of any material with varying fill weights and with different closure techniques, providing an extremely versatile solution to customers looking for high flexibility.

More Videos


  • RoosterBio Selects BioLife Solutions CryoStor® To Commercialize Human Bone Marrow-Derived Stem Cells

    BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), announced today that Frederick, MD based RoosterBio, Inc., has adopted the Company's CryoStor clinical grade cryopreservation freeze media to commercialize RoosterBio's human bone marrow-derived, adult mesenchymal stem cell (hMSC) products.

More News


  • Brookfield Engineering Laboratories, Inc.
    Brookfield Engineering Laboratories, Inc. Brookfield is the world's leading manufacturer of viscometers and rheometers for the pharmaceutical industry. The rotational method of viscosity measurement enables complete flow curve characterization for pharmaceutical materials.
  • 3M Purification
    3M Purification

    3M Purification (formerly CUNO) core filtration technologies address the most demanding applications in pharmaceutical processing for small molecule and active pharmaceutical ingredient (API) applications.

  • AT&T

    AT&T Inc. (NYSE:T) is a premier communications holding company and one of the most honored companies in the world. Its subsidiaries and affiliates – AT&T operating companies – are the providers of AT&T services in the United States and internationally. With a powerful array of network resources that includes the nation’s fastest and most reliable 4G LTE network, AT&T is a leading provider of wireless, Wi-Fi, high speed Internet, voice and cloud-based services.

  • Weiler Engineering, Inc.
    Weiler Engineering, Inc.

    Weiler Engineering is America's leading provider of aseptic Blow/Fill/Seal liquid packaging machines for pharmaceutical and healthcare applications





Life Science Leader developed the CMO and CRO Leadership Awards based on industry leading research conducted by Nice Insight. The awards help pharma and biopharm companies focus on potential partners who can handle their projects and are considered reputable in the industry. Click on the logos above to visit this year’s winners.




The Information Source for the Pharmaceutical Manufacturing Industry

Welcome to Pharmaceutical Online, the premier sourcing site for the pharmaceutical manufacturing industry, find industry information on critical environment, particle sizing, pharma process control, pharma material handling, tablet production, pharma sterilizing, pharma cleaning, pharma filtration, pharma packaging, pharma inspection, & much more. Use our product showcase, and offline search service to expedite your discovery of new products and services. Our goal is to help buyers, like you, identify and select suppliers.

Pharmaceutical Online is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute. Please take a moment to join our community and discover the benefits of your free membership.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.


As the highly anticipated November debut of Pharma EXPO approaches, we’ve developed this resource center for our readers to access the most relevant information about the event. 

Learn More


Stability Programs - Key Factors in Meeting FDA/ICH Regulations

December 10, 2014
1pm-2:30pm EST, Online Training

Identifying and Closing the Training Gap in Clinical Research

January 6, 2015
1pm-2:30pm EST, Online Training

Building Accountability on Your Clinical Teams

January 8, 2015
1pm-2:30pm EST, Online Training

Pediatric Clinical Trials: Special Considerations and Requirements

January 12, 2015
1pm-2:30pm EST, Online Training

Aseptic Processing: Preparing Staff and Programs For Compliance

January 13, 2015
1pm-2:30pm EST, Online Training
More Upcoming Courses


More From Life Science Webinars




World Open Innovation Forum 2014

November 26 - 27, 2014

World Drug Manufacturing Summit

December 1 - 3, 2014
Berlin, ZZ


December 1 - 3, 2014
Rembrandt Hotel, 11 Thurlow Place, London SW7 2RS
More Events....


Feed Image
RT @PharmTechGroup: Expert from J&J's Janssen discusses global regulatory compliance for product registrations. Free June 11 webcast. http…
3 hours ago

06.11.13 -- Temperature Monitoring Comparisons For The Pharmaceutical Supply Chain
3 hours ago